Stay updated on Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated to v3.5.0 and the previous v3.4.3 label was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedUpdated page revision label to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 was added; notices about government funding and the prior revision (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedAdded a government funding lapse notice and updated the page template to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a 'Show glossary' feature and updated footer/labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the revision to v3.4.0. The changes are cosmetic and do not modify the study information.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus+Pazopanib in Nonadipocytic Soft Tissue Sarcomas Clinical Trial page.